News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Kevin Conroy: Katherine is an incredible reminder of the 20-year impact Oncotype DX has made on breast cancer
Photo from Kevin Conroy/LinkedIn
Jul 26, 2024, 19:50

Kevin Conroy: Katherine is an incredible reminder of the 20-year impact Oncotype DX has made on breast cancer

Kevin Conroy, Chairman and CEO at Exact Sciences, shared on LinkedIn:

“Our patients are at the heart of everything we do at Exact Sciences. Meet Katherine, our first-ever Oncotype DX Breast Recurrence Score test patient. I was thrilled to connect with her recently.

Katherine was diagnosed with breast cancer in 2004 and was able to forgo chemotherapy after receiving her test results. She’s an incredible reminder of the 20-year impact Oncotype DX has made on breast cancer and aiding in personalized treatment decisions.”

Source: Kevin Conroy/LinkedIn

Breast Cancer cancer chemotherapy Exact Sciences Kevin Conroy OncoDaily Oncology Oncotype DX Breast Recurrence Score patients treatment
Special Coverage
Blog
Jan 26, 2025, 08:59
Andrea Apolo: We NEED the NIH and we NEED to continue to do our science
Career
Jan 26, 2025, 08:48
Shruti Patel: Open Faculty Positions at Stanford Cancer Institute
Blog
Jan 26, 2025, 08:46
Jacquelyne Gaddy: Biggest Informed Believer that I know
Insight
Jan 26, 2025, 08:41
Sumanta K. Pal: Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management
Blog
Jan 26, 2025, 08:37
Daniel Chang: Nina Niu Sanford on the role of organ preservation for gastroesophageal cancer at ASCO GI25
Science
Jan 26, 2025, 08:34
Cristiane Bergerot: HRQoL Assessments in Research on Patients with Adult Rare Solid Cancers
Blog
Jan 26, 2025, 08:17
Sneha Singh: Thrilled to be presenting at ASCO GI
Blog
Jan 26, 2025, 08:11
Cathy Eng: Packed house at the 'Women Excelling in G.I. Oncology'
Science
Jan 26, 2025, 08:08
Paolo Tarantino: Taxanes vs Eribulin for First-Line Metastatic HER2+ Breast Cancer
Blog
Jan 26, 2025, 08:06
Dean Crowe: More than $2.5M to amazing pediatric cancer research at Emory University
Blog
Jan 26, 2025, 08:04
Antonio D'Alessio: RACB Study conversion therapy with AtezoBev in initially unresectable HCC
Blog
Jan 26, 2025, 08:02
Sanam Loghavi: An opening for our 2025-2026 Hematopathology Fellowship at MD Anderson Cancer Center